These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25589785)

  • 21. The Polar Region of the HIV-1 Envelope Protein Determines Viral Fusion and Infectivity by Stabilizing the gp120-gp41 Association.
    Lu W; Chen S; Yu J; Behrens R; Wiggins J; Sherer N; Liu SL; Xiong Y; Xiang SH; Wu L
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Membrane-anchored inhibitory peptides capture human immunodeficiency virus type 1 gp41 conformations that engage the target membrane prior to fusion.
    Melikyan GB; Egelhofer M; von Laer D
    J Virol; 2006 Apr; 80(7):3249-58. PubMed ID: 16537592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in understanding the molecular mechanisms of HIV-1 entry and fusion: revisiting current targets and considering new options for therapeutic intervention.
    Markovic I; Clouse KA
    Curr HIV Res; 2004 Jul; 2(3):223-34. PubMed ID: 15279586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 gp41: mediator of fusion and target for inhibition.
    Weiss CD
    AIDS Rev; 2003; 5(4):214-21. PubMed ID: 15012000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus.
    Etemad-Moghadam B; Rhone D; Steenbeke T; Sun Y; Manola J; Gelman R; Fanton JW; Racz P; Tenner-Racz K; Axthelm MK; Letvin NL; Sodroski J
    J Virol; 2001 Jun; 75(12):5646-55. PubMed ID: 11356972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct functions for the membrane-proximal ectodomain region (MPER) of HIV-1 gp41 in cell-free and cell-cell viral transmission and cell-cell fusion.
    Narasimhulu VGS; Bellamy-McIntyre AK; Laumaea AE; Lay CS; Harrison DN; King HAD; Drummer HE; Poumbourios P
    J Biol Chem; 2018 Apr; 293(16):6099-6120. PubMed ID: 29496992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of CA Content and CPSF6 Dependence of Early HIV-1 Replication Complexes in SupT1-R5 Cells.
    Zila V; Müller TG; Laketa V; Müller B; Kräusslich HG
    mBio; 2019 Nov; 10(6):. PubMed ID: 31690677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
    Raja NU; Vincent MJ; Jabbar MA
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of HIV-1 entry into CD4+ T cells.
    Stein BS; Engleman EG
    Adv Exp Med Biol; 1991; 300():71-86; discussion 87-96. PubMed ID: 1685857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fully hydrophobic HIV gp41 adopts a hemifusion-like conformation in phospholipid bilayers.
    Lee M; Morgan CA; Hong M
    J Biol Chem; 2019 Oct; 294(40):14732-14744. PubMed ID: 31409642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins.
    Berlioz-Torrent C; Shacklett BL; Erdtmann L; Delamarre L; Bouchaert I; Sonigo P; Dokhelar MC; Benarous R
    J Virol; 1999 Feb; 73(2):1350-61. PubMed ID: 9882340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.
    Finnegan CM; Berg W; Lewis GK; DeVico AL
    J Virol; 2002 Dec; 76(23):12123-34. PubMed ID: 12414953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide-based inhibitors of the HIV envelope protein and other class I viral fusion proteins.
    Steffen I; Pöhlmann S
    Curr Pharm Des; 2010; 16(9):1143-58. PubMed ID: 20030613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visualization of Content Release from Cell Surface-Attached Single HIV-1 Particles Carrying an Extra-Viral Fluorescent pH-Sensor.
    Sood C; Marin M; Mason CS; Melikyan GB
    PLoS One; 2016; 11(2):e0148944. PubMed ID: 26863211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interhelical interactions in the gp41 core: implications for activation of HIV-1 membrane fusion.
    Wang S; York J; Shu W; Stoller MO; Nunberg JH; Lu M
    Biochemistry; 2002 Jun; 41(23):7283-92. PubMed ID: 12044159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus.
    Bergeron L; Sullivan N; Sodroski J
    J Virol; 1992 Apr; 66(4):2389-97. PubMed ID: 1548769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity.
    Murakami T; Ablan S; Freed EO; Tanaka Y
    J Virol; 2004 Jan; 78(2):1026-31. PubMed ID: 14694135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4 activation of HIV fusion.
    Sattentau QJ
    Int J Cell Cloning; 1992 Nov; 10(6):323-32. PubMed ID: 1281202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor.
    Derdeyn CA; Decker JM; Sfakianos JN; Zhang Z; O'Brien WA; Ratner L; Shaw GM; Hunter E
    J Virol; 2001 Sep; 75(18):8605-14. PubMed ID: 11507206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Actin cytoskeletal reorganizations and coreceptor-mediated activation of rac during human immunodeficiency virus-induced cell fusion.
    Pontow SE; Heyden NV; Wei S; Ratner L
    J Virol; 2004 Jul; 78(13):7138-47. PubMed ID: 15194790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.